MEDTOX Scientific (MTOX) Posts Q2 EPS of $0.11, Short of Views
MEDTOX Scientific, Inc. (Nasdaq: MTOX) reports Q2 EPS of $0.11, versus the analyst estimate of $0.13. Revenue for the quarter was $25.2 million, which compares to the estimate of $23.63 million.
You May Also Be Interested In
- Tesla (TSLA) Offers to Acquire SolarCity (SCTY) for $26.50-$28.50/Share
- Finish Line (FINL) Gains in Sea of Red Amid EPS
- BlackBerry (BBRY) Tops Q1 EPS by 8c; Guides for Narrower-than-Expected Loss in FY17
Create E-mail Alert Related CategoriesEarnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!